Profile

Cover photo
Mendy Schurder
Lives in Boca Raton, FL
210 followers|37,078 views
AboutPostsPhotosVideos+1's

Stream

Mendy Schurder

Shared publicly  - 
 
Asthma is a lung disease that affects almost 20 million Americans. COPD, or chronic obstructive pulmonary disease is a chronic lung disease that afflicts 24 million patients in the U.S. COPD is mainly caused by smoking or secondhand smoke, while asthma can by caused by exposure to allergens, dust and air pollutants. Innovative treatments are needed to combat both asthma and COPD, and LGM Pharma provides quality API's for the R&D needs of clients ...
1
Add a comment...

Mendy Schurder

Shared publicly  - 
 
FDA Approves Dalbavancin for the Treatment of Acute Skin Infections - Known as the brand name Dalvance, the FDA nod for Dalbavancin meets a current need for new, safe and efficacious antibiotics. http://www.lgmpharma.com/blog/fda-approves-dalbavancin-treatment-acute-skin-infections/
1
Add a comment...

Mendy Schurder

Shared publicly  - 
 
FDA Grants Accelerated Approval to Ceritinib For ALK- Positive NSCLC - The FDA granted an accelerated approval of Ceritinib on April 29, 2014 for patients with ALK-positive NSCLC that is unresectable and unresponsive to previous treatment with Crizotinib. http://www.lgmpharma.com/blog/fda-grants-accelerated-approval-ceritinib-alk-positive-nsclc/
1
Add a comment...

Mendy Schurder

Shared publicly  - 
 
Dapagliflozin and Saxagliptin Make a Dazzling Duo - Data recently released from the 534 patient, three-arm Phase lll trial showed Dapagliflozin and Saxagliptin alongside Metformin was superior. http://www.lgmpharma.com/blog/dapagliflozin-saxagliptin-make-dazzling-duo/
1
Add a comment...
Have him in circles
210 people
Eugene Sefanov's profile photo
Hospital Furniture | Medical Furniture Manufacturer's profile photo
Tondelia Knox's profile photo
Dana-Farber Cancer Institute's profile photo
tomar trave's profile photo
Momenul Ahmad's profile photo
Tbro ekyitagi's profile photo
David Kenyon's profile photo
Pablo Grigera's profile photo
 
Concerns for patients with myelodysplastic syndrome (MDS) being administered this potent anti-cancer drug were quelled, when a comprehensive study revealed that this lifesaving treatment did not lead to a transformation to AML in Lenalidomide patients. #leukemia #lymphoma #cancer   http://www.lgmpharma.com/blog/increased-risk-aml-lenalidomide-drug-recipients/
1
Add a comment...
 
Pancreatic Cancer Predicted to Become the Second Cause of U.S. Cancer Deaths - A report issued from the Pancreatic Cancer Action Network predicted that pancreatic cancer will become the #2 cause of cancer deaths by 2030 http://www.lgmpharma.com/blog/pancreatic-cancer-predicted-become-second-cause-u-s-cancer-deaths/
1
Add a comment...

Mendy Schurder

Shared publicly  - 
 
Idelalisib Is a Leader in Oncology Treatment - A green light for Idelalisib is expected later this summer as this unique P13K delta inhibitor has proven viable both as a single agent and in combination with other anti- cancer drugs. http://www.lgmpharma.com/blog/idelalisib-leader-oncology-treatment/
1
Add a comment...

Mendy Schurder

Shared publicly  - 
 
Erdosteine Attains Orphan-Drug Status from the FDA - There are currently no medications approved in the United States for the treatment of Bronchiectasis, therefore the ultimate approval of Erdosteine would be beneficial for this urgent unmet need. http://www.lgmpharma.com/blog/erdosteine-attains-orphan-drug-status-fda/
1
Add a comment...
 
FDA Approves Ketorolac and Phenylephrine for Eye Surgery - Approx. 4 million Americans undergo cataract surgery every year, so the FDA approval of Ketorolac and Phenylephrine is beneficial for many. http://www.lgmpharma.com/blog/fda-approves-ketorolac-phenylephrine-eye-surgery/
1
Add a comment...

Mendy Schurder

Shared publicly  - 
 
Vemurafenib and Cobimetinib - A Dynamic Duo in the Fight Against Melanoma - Roche and Exelixis revealed that early stage trials of Vemurafenib and Cobimetinib have shown extended survival, Phase 3 study to commence. http://www.lgmpharma.com/blog/vemurafenib-cobimetinib-dynamic-duo-fight-melanoma/
1
Add a comment...
People
Have him in circles
210 people
Eugene Sefanov's profile photo
Hospital Furniture | Medical Furniture Manufacturer's profile photo
Tondelia Knox's profile photo
Dana-Farber Cancer Institute's profile photo
tomar trave's profile photo
Momenul Ahmad's profile photo
Tbro ekyitagi's profile photo
David Kenyon's profile photo
Pablo Grigera's profile photo
Places
Map of the places this user has livedMap of the places this user has livedMap of the places this user has lived
Currently
Boca Raton, FL
Previously
Boca Raton
Contact Information
Work
Phone
1-(800)-881-8210
Address
3200 West End Ave, Suite 500, Nashville, TN 37203
Story
Tagline
Supplying API's Today, For Tomorrow's Innovative Drug Therapies
Introduction
Pleasure to meet you! I am the COO of LGM Pharma. LGM Pharma is an active pharmaceutical ingredient supplier to the pharmaceutical industry in the U.S. and abroad. Check out our website: www.lgmpharma.com.
Bragging rights
Sole Distributor of TEVA API's (TAPI) for their extensive API portfolio, for the US pharmacy compounding market.
Work
Occupation
Active Pharmaceutical Ingredient Supplier
Basic Information
Gender
Male
Looking for
Networking
Mendy Schurder's +1's are the things they like, agree with, or want to recommend.
Streetsblog New York City
www.streetsblog.org

In a matter of months, Families For Safe Streets became a powerful force for policies that protect people from traffic violence. Every membe

Gifting it Away - Gifting Strategies That Reduce Estate Taxes | BPM Blog...
blog.bpmcpa.com

Death and taxes are a given, but here's how you can avoid paying the highest premiums on your estate taxes.

LGM Pharma Appoints OTC Sales Director
www.contractpharma.com

Miller to implement sales strategies for OTC division

Cancer Drugs with Breakthrough Status - on a Fast Track, But is it Fast ...
www.lgmpharma.com

3 Breakthrough status Cancer drugs, which their respective manufacturers hope to market in as short of a time period as possible.

Escitalopram Prevents Mental Stress-Induced Myocardial Ischemia in Patie...
www.lgmpharma.com

Patients who had stable coronary artery disease and were administered Escitalopram had a lower rate of MSIMI compared to placebo

Development of New Antibiotics Needed for Drug Resistant Bacteria-Will T...
www.lgmpharma.com

On March 25, 2013 Trius Therapeutics announced that their new second-generation antibiotic tedizolid phosphate is succeeding in clinical tri

Can Testosterone Be Used As a Preventative Treatment For Type 2 Diabetes...
www.lgmpharma.com

Coined “The Wittert Study”, after Gary Wittert who is the leader of this study, this study is banking on being the first of many to address

FDA Approves Twice a Day Dose of Dimethyl Fumarate for MS - LGM Pharma Blog
www.lgmpharma.com

The recent approval of Dimethyl Fumarate was an encouraging sign for the 2.5 million patients worldwide suffering with Multiple Sclerosis.

Empagliflozin - A New Once Daily Tablet Treatment for Type 2 Diabetes - ...
www.lgmpharma.com

On March 25, 2013 Empagliflozin was announced as a novel and unique once daily tablet for type 2 diabetes treatment.

FDA Approves New Indication for Budesonide - LGM Pharma Blog
www.lgmpharma.com

On January 15, 2013 Santarus, Inc. announced that the FDA had approved Budesonide, as the brand name Ulceris, for the induction of remission

Is Oxybutynin a Solution for Patients with Overactive Bladder Condition?...
www.lgmpharma.com

Oxybutynin, CAS# 5633-20-5, is known as the brand name Oxytrol. Marketed by Watson, this medication used to treat overactive bladder has a p

Lidocaine and Tetracaine Work Together in a Novel Anesthetic Patch « LGM...
www.lgmpharma.com

needle in arm Known as Synera, which is marketed by Nuvo Research and ZARS Pharmaceutical Inc., this topical anesthetic patch is due to have

Gatifloxacin Is An Available and Effective Antibiotic « LGM Pharma Blog
www.lgmpharma.com

Gatifloxacin is a quinolone antibiotic also known as Tequin. While Tequin, which is marketed by Bristol- Myers Squibb is no longer sold as a

Exciting and Encouraging News for Linaclotide « LGM Pharma Blog
www.lgmpharma.com

linaclotide On August 30, 2012 Ironwood Pharmaceuticals Inc. and Forest Laboratories Inc. gained U.S. regulatory approval of linaclotide for

Famotidine is an Effective Treatment for GERD « LGM Pharma Blog
www.lgmpharma.com

famotidine Histamine-2 blockers are commonly prescribed for patients with gastroesophageal reflux disease, also known as GERD. Famotidine is

Lilly Alzheimer's Drug Disappoints
online.wsj.com

A closely watched Alzheimer's drug from Eli Lilly failed to work in two late-stage clinical trials in patients with mild-to-to moderate leve

Fenofibrate Safe for Patients with Type 2 Diabetes « LGM Pharma Blog
www.lgmpharma.com

Fenofibrate, CAS number 49562-28-9, is known as the brand name Lipofen, which is marketed by Cipher-Kowa Pharmaceuticals. The patent for Lip

Fungal Infections Face a Force to be Reckoned With-Amphotericin B « LGM ...
www.lgmpharma.com

Amphotericin B, CAS number 1397-89-3, is also known as the brand name Ambisone. With Astellas Pharma's patent for Ambisome due to expire on

Eptifibatide Continues to be Successful as an Antiplatelet Agent « LGM P...
www.lgmpharma.com

Eptifibatide, CAS# 188627-80-7, is an antiplatelet agent. Also offered from LGM Pharma as a TEVA API (TAPI) product for compounding purposes